SCHEMBL7722875

SCHEMBL7722875

CCOC(=O)C1=C(c2cc(C(F)(F)F)ccc2NC(=O)C(C)(C)C)CCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAPT P10636 3/20 0.40
SLC6A3 Q01959 1/20 0.40
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
CHRM3 P20309 2/20 0.38
PDK1 Q15118 1/20 0.38
PDK2 Q15119 1/20 0.38
PDK3 Q15120 1/20 0.38
PDK4 Q16654 1/20 0.38
KDM4E B2RXH2 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ALDH1A1 P00352 2/20 0.37
TLR2 O60603 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6641855 0.84 CYP1A2 (0.39) NPC1HTTRAB9ASMN1; SMN2MAPT
SCHEMBL5662430 0.82 KDM4E (0.46) NPC1HTTRAB9ASMN1; SMN2MAPT
SCHEMBL7726271 0.76 ALDH1A1 (0.43) NPC1HTTRAB9ASMN1; SMN2MAPT
SCHEMBL6503781 0.73 SLC6A2 (0.56) MAPTSLC6A3CHRM3KDM4EALDH1A1
SCHEMBL6503784 0.73 SLC6A2 (0.56) MAPTSLC6A3CHRM3KDM4EALDH1A1
SCHEMBL8946084 0.71 GAA (0.48) HTTRAB9AMAPTCYP1A2CYP2C9
SCHEMBL14514642 0.69 PTGER1 (0.45) HTTSLC6A3CYP2C9KDM4EKMT2A
SCHEMBL17318391 0.68 ALDH1A1 (0.49) SMN1; SMN2MAPTKDM4EALDH1A1MEN1
SCHEMBL13015660 0.67 KIF11 (0.52) RAB9ACYP1A2CYP2C9PDK1PDK2
SCHEMBL2107755 0.67 ALOX5 (0.43) MAPTSLC6A3CHRM3KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6391887-B1 ANTIINFLAMMATORY AGENTS; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISORDERS SCHERING AKTIENGESELLSCHAFT (DE) 2002-05-21 US disclosed